Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Pilot Clinical Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

NCT02959151 is registered in ClinicalTrials.gov with Shanghai GeneChem Co., Ltd. as lead sponsor.

NCT NCT02959151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02959151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Pilot Clinical Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Lead sponsor
Shanghai GeneChem Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, colorectal cancer metastatic, pancreatic cancer metastatic